Last checked at 12 Sep 2014 07:00
Glanbia acquires sports nutrition brand, Isopure
12 September 2014 - Glanbia plc ('Glanbia' or the 'Group'), the global performance nutrition and ingredients group, announces that it has agreed to acquire The Isopure Company, LLC (the "Business" or "Isopure") (www.theisopurecompany.com) for cash consideration of US$153 million (the "Transaction").
Isopure is a US based provider of premium branded sports nutrition products. The Business focuses on powders and ready-to-drink ('RTD') formats, primarily through the specialty, internet and direct distribution channels. Isopure generated net revenues of US$74.6 million for the twelve month period to the end of July. This represents a CAGR of 20% for the period from end December 2011 to end July 2014.
Isopure's premium brand complements the portfolio of Glanbia's Global Performance Nutrition ('GPN') business and the acquisition further consolidates GPN's market leading position. The acquisition is expected to be earnings accretive from 2015 and will be funded from the Group's existing debt facilities.
It is anticipated that the Transaction will complete in the fourth quarter of 2014 subject to customary completion conditions and regulatory approval.
Commenting today, Siobhán Talbot, Group Managing Director said:
"We are delighted to announce the acquisition of Isopure. As a premium brand, the Business is an excellent addition to our portfolio of market leading performance nutrition brands and provides an opportunity to leverage our infrastructure and capabilities to drive future growth. The transaction, which is firmly aligned with the Group's strategy, supports our growth ambitions and will be value enhancing for our shareholders."
About Glanbia
Glanbia plc is a global performance nutrition and ingredients group with leading market positions in sports nutrition, cheese, specialty dairy and non-dairy ingredients and micronutrient premixes. The Group is comprised of four business segments - Global Performance Nutrition, Global Ingredients, Dairy Ireland and Joint Ventures & Associates. The Group employs over 5,000 people in 32 countries. Glanbia shares are listed on the Irish and London Stock exchanges (symbol: GLB).
Glanbia's B2C Global Performance Nutrition segment is the global leader in sports nutrition with a direct presence in 19 countries worldwide and product sales in more than 100 countries. Its brand portfolio includes Optimum Nutrition, BSN, ABB and Nutramino. Global Performance Nutrition's portfolio of products covers all key sports categories including protein, muscle gainers and builders, pre-workout and general health.
For further information contact
Glanbia plc +353 56 777 2200
Mark Garvey, Group Finance Director
Shane Power, Head of Investor Relations +353 87 665 6315
Geraldine Kearney, Corporate Communications Director + 353 87 231 9430